Creative unavailable
James Kilgour, MD
James Kilgour, MD

Inactive· since Aug 10, 2026

34
days it ran
0
relaunches

Ad copy

We just published clinical trial results the hair loss industry is going to hate. Because for the first time, someone tested a hair protocol for menopausal women the way pharmaceutical drugs get tested… Except it isn't a drug, and it comes with none of the side effects. See, a few years back, my mom lost her hair to menopause. I'm a Stanford-trained dermatologist, and I still couldn't stop it. Minoxidil failed her — six months in, all it gave her was the dread shed and hair that came back thin. And I realized if I wanted something that actually worked, I'd have to build it myself. So I went through hundreds of studies. And I pulled out the actives with the hardest proof behind them. One's called AnaGain — a hair cycle active that nearly doubled the number of hairs actively growing. One's called Redensyl — a hair growth active that grew over 10,000 new hairs across the scalp. More than three hair transplants' worth, without a single needle. One's called Procapil — an anti-shedding peptide that reinforces the grip at the base of the follicle, and cut hair fall by up to 46%. One's called Capixyl — a density peptide shown to increase hair density by 79%, and to cut the scalp inflammation that shortens how long each hair gets to grow by 48%. And the combination was tested head-to-head against minoxidil and beat it more than two to one. Then I handed the finished formula to an independent lab called Dermaclaim and let them test it. The results broke records. Shedding dropped as much as 68% by week 6 — the long hairs, the ones clogging your drain. And density climbed a full grade on the Ludwig scale, scored by two independent dermatologists — up to three times faster than minoxidil. It's now peer-reviewed and published in the Journal of Drugs in Dermatology, under the title “Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss.” No other hair product has ever been tested this rigorously on menopausal women. Most brands won't even try. Because most products don't survive this level of scrutiny. That's why, through FrontRowMD, more than 1,400 clinicians now put their names behind it. And 200,000 women use it. Now here's why I'm posting this. To mark the publication we've put together a special offer on the full two-serum protocol — the same one every woman in the trial used. Two serums, sixty seconds on the scalp before bed. It runs for a limited time. After that the price goes back to normal and stays there. And you don't have to take my word for any of it. Use it every night for ninety days, and if your shedding isn't down and nothing's filling in, one email and every penny comes back. You keep the bottles.

Scalp trick to stop menopausal hair loss fast

LEARN MORE
🪄Crush AI

Like this ad? Make it yours.

Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.

More ads from James Kilgour, MD

James Kilgour, MDJames Kilgour, MD
Inactive
7 Days
-Reach
22Ads
James Kilgour, MD Facebook ad
Details
James Kilgour, MDJames Kilgour, MD
Inactive
7 Days
-Reach
17Ads
James Kilgour, MD Facebook ad
Details
James Kilgour, MDJames Kilgour, MD
Inactive
5 Days
-Reach
15Ads
James Kilgour, MD Facebook ad
Details
James Kilgour, MDJames Kilgour, MD
Active
31 Days
-Reach
12Ads
James Kilgour, MD Facebook ad
Details
James Kilgour, MDJames Kilgour, MD
Inactive
20 Days
-Reach
12Ads
James Kilgour, MD Facebook ad
Details
James Kilgour, MDJames Kilgour, MD
Inactive
7 Days
-Reach
10Ads
James Kilgour, MD Facebook ad
Details
James Kilgour, MDJames Kilgour, MD
Inactive
4 Days
-Reach
9Ads
James Kilgour, MD Facebook ad
Details
James Kilgour, MDJames Kilgour, MD
Inactive
28 Days
-Reach
9Ads
James Kilgour, MD Facebook ad
Details
James Kilgour, MD Ad — Ran 34 Days | Crush Ad Library